• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿托伐他汀可增加人类终末期腹主动脉瘤病灶内 BAX 和 BAK 的表达。

Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms.

机构信息

Department of Endocrinology, Sir Mortimer B. Davis-Jewish General Hospital, 3755 chemin Côte Ste Catherine, Montréal, QC H3T 1E2, Canada.

出版信息

Can J Physiol Pharmacol. 2009 Nov;87(11):915-22. doi: 10.1139/y09-085.

DOI:10.1139/y09-085
PMID:19935899
Abstract

Chronic apoptosis activation may participate in abdominal aortic aneurysm (AAA) expansion. Statin treatment slows AAA progression independent of cholesterol lowering. We hypothesized that Atorvastatin treatment alters apoptosis protein expression and activation in AAAs. Protein was isolated from the central and distal portions of end-stage human AAA tissue obtained during surgical repair from non-statin (NST) and Atorvastatin-treated (AT) patients. Expression was compared using immunoblots. Bcl-2 expression was unchanged but Bak (4-fold, p < 0.013) and Bax (3-fold, p < 0.035) expression was increased in AT (n = 12) versus NST (n = 15) patients. No cytochrome c release or caspase 3 activation was detected and Clusterin, GRP78, and BNIP1 expression was similar in NST and AT samples. Bcl-2 and Bax cDNA sequences from AAA tissue (n = 10) and the general population were identical. Thus, the increase in Bax and Bak in AT-treated AAAs did not activate the mitochondria or endoplasmic reticulum mediated apoptosis pathways. Bcl-2, Bax, and Bak have non-apoptosis related functions that include maintenance of endoplasmic reticulum (ER), homeostasis, and adaptation to stress. We speculate that Atorvastatin-mediated increases in Bax and Bak may positively affect their non-apoptosis related cell functions to account for the beneficial effect of statins to slow AAA expansion.

摘要

慢性细胞凋亡激活可能参与腹主动脉瘤(AAA)的扩张。他汀类药物治疗可减缓 AAA 的进展,而不依赖于降低胆固醇。我们假设阿托伐他汀治疗可改变 AAA 中凋亡蛋白的表达和激活。从接受他汀类药物(AT)治疗和未接受他汀类药物(NST)治疗的患者的外科修复术中获得终末期人 AAA 组织的中央和远端部分分离出蛋白质。使用免疫印迹比较表达。Bcl-2 的表达保持不变,但 Bak(4 倍,p < 0.013)和 Bax(3 倍,p < 0.035)的表达在 AT(n = 12)患者中高于 NST(n = 15)患者。未检测到细胞色素 c 释放或 caspase 3 激活,NST 和 AT 样本中的 Clusterin、GRP78 和 BNIP1 表达相似。从 AAA 组织(n = 10)和普通人群中分离出的 Bcl-2 和 Bax cDNA 序列相同。因此,AT 治疗的 AAA 中 Bax 和 Bak 的增加并未激活线粒体或内质网介导的细胞凋亡途径。Bcl-2、Bax 和 Bak 具有非凋亡相关的功能,包括维持内质网(ER)、体内平衡和适应应激。我们推测,阿托伐他汀介导的 Bax 和 Bak 增加可能会对其非凋亡相关的细胞功能产生积极影响,从而解释他汀类药物减缓 AAA 扩张的有益作用。

相似文献

1
Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms.阿托伐他汀可增加人类终末期腹主动脉瘤病灶内 BAX 和 BAK 的表达。
Can J Physiol Pharmacol. 2009 Nov;87(11):915-22. doi: 10.1139/y09-085.
2
Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.阿托伐他汀可调节腹主动脉瘤中基质金属蛋白酶的表达、活性及信号传导。
Vasc Endovascular Surg. 2010 Feb;44(2):116-22. doi: 10.1177/1538574409348352. Epub 2009 Dec 23.
3
Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.常用他汀类药物对腹主动脉瘤壁生物学的不同影响。
Eur J Vasc Endovasc Surg. 2010 May;39(5):569-76. doi: 10.1016/j.ejvs.2010.01.030. Epub 2010 Mar 11.
4
Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.普伐他汀可增加人腹主动脉瘤中基质金属蛋白酶组织抑制因子-1和癌基因Bax的表达。
Can J Physiol Pharmacol. 2008 Jul;86(7):431-7. doi: 10.1139/y08-060.
5
Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.对利妥昔单抗的获得性耐药与因Bax和Bak表达降低导致的化疗耐药相关。
Clin Cancer Res. 2008 Mar 1;14(5):1550-60. doi: 10.1158/1078-0432.CCR-07-1255.
6
High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.大剂量阿托伐他汀可改善高胆固醇血症患者的冠状动脉内皮功能障碍,但不能改善血管生成反应。
Circulation. 2006 Jul 4;114(1 Suppl):I402-8. doi: 10.1161/CIRCULATIONAHA.105.000356.
7
Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells.电离辐射利用c-Jun氨基末端激酶来放大人类宫颈癌细胞中线粒体凋亡性细胞死亡。
FEBS J. 2008 May;275(9):2096-108. doi: 10.1111/j.1742-4658.2008.06363.x. Epub 2008 Mar 28.
8
Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins.巨细胞病毒利用两种不同的病毒蛋白抑制 Bak 和 Bax 介导的细胞凋亡。
Cell Death Differ. 2010 Apr;17(4):655-65. doi: 10.1038/cdd.2009.147. Epub 2009 Oct 9.
9
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.羟甲基戊二酰辅酶A还原酶抑制剂在体外可诱导人心脏心肌细胞凋亡。
Biochem Pharmacol. 2006 Apr 28;71(9):1324-30. doi: 10.1016/j.bcp.2006.01.016. Epub 2006 Mar 15.
10
Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.促凋亡分子Bax和Bak参与肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的线粒体破坏和凋亡:细胞色素c和Smac/DIABLO释放的差异调节
Cancer Res. 2003 Apr 1;63(7):1712-21.

引用本文的文献

1
Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells.辛伐他汀诱导未折叠蛋白反应并增强胶质母细胞瘤细胞中替莫唑胺诱导的细胞死亡。
Cells. 2020 Oct 22;9(11):2339. doi: 10.3390/cells9112339.
2
Aneurysm Severity is Increased by Combined Mmp-7 Deletion and N-cadherin Mimetic (EC4-Fc) Over-Expression.Mmp-7 缺失和 N-钙黏蛋白模拟物(EC4-Fc)过表达增加动脉瘤严重程度。
Sci Rep. 2017 Dec 11;7(1):17342. doi: 10.1038/s41598-017-17700-8.
3
Direct Activation of Bax Protein for Cancer Therapy.用于癌症治疗的 Bax 蛋白直接激活
Med Res Rev. 2016 Mar;36(2):313-41. doi: 10.1002/med.21379. Epub 2015 Sep 23.
4
Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts.他汀类药物抑制甲羟戊酸通路诱导人心房成纤维细胞死亡过程中的细胞凋亡、自噬和内质网应激
Cell Death Dis. 2012 Jun 21;3(6):e330. doi: 10.1038/cddis.2012.61.